Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ)
KRW 10440.0
(-2.61%)
KRW 10440.0
(-2.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 13.72 Million | - | - | - | - |
| Cost of Revenue | 6.59 Million | 16.43 Million | 19.37 Million | 5.38 Million | 13.3 Million |
| Gross Profit | 7.12 Million | -16.43 Million | -19.37 Million | -5.38 Million | -13.3 Million |
| Operating Expenses | 11.51 Billion | 8.21 Billion | 5.9 Billion | 4.25 Billion | 676.47 Million |
| Selling, General and Administrative Expenses | 3.2 Billion | 2.34 Billion | 1.64 Billion | 1.06 Billion | 2.85 Billion |
| Research and Development Expenses | 4.91 Billion | 2.07 Billion | 1.81 Billion | 1.34 Billion | 954.3 Million |
| Other Expenses | 3.39 Billion | 1 Billion | 867.23 Million | 216.05 Million | - |
| Cost and Expenses | 11.52 Billion | 8.21 Billion | 5.9 Billion | 4.25 Billion | 689.77 Million |
| Operating Income | -11.5 Billion | -8.21 Billion | -5.9 Billion | -4.25 Billion | -4.01 Billion |
| Interest Expense | 43.66 Million | 16.67 Million | 26.89 Million | 34.89 Million | - |
| Income Tax Expense | - | 1.42 Billion | 1.18 Billion | 325.77 Million | - |
| Earnings before Tax | -10.27 Billion | -6.82 Billion | -4.76 Billion | -3.98 Billion | -1.25 Billion |
| Net Income | -10.27 Billion | -6.82 Billion | -4.76 Billion | -3.98 Billion | -1.25 Billion |
| Earnings Per Share Basic | -524.00 | -337.56 | -237.35 | -441.14 | -286.00 |
| Earnings Per Share Diluted | -524.00 | -337.56 | -237.35 | -441.14 | -286.00 |
| Weighted Average Shares Outstanding | 19.6 Million | 20.21 Million | 20.06 Million | 9.03 Million | 4.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.6 Million | 20.21 Million | 20.06 Million | 9.03 Million | 4.38 Million |
| Gross Margin | 0.52 | - | - | - | - |
| EBIT Margin | -716.35 | - | - | - | - |
| Profit Margin | -748.66 | - | - | - | - |
| EBITDA | -9.83 Billion | -6.47 Billion | -4.45 Billion | -3.74 Billion | -3.82 Billion |
| Earnings Before Tax Margin | -838.51 | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 29.23 Million | 26.63 Million | 13.72 Million | 13.72 Million | - | - |
| Cost of Revenue | 12.7 Million | 13.64 Million | 7.11 Million | 6.59 Million | 1.06 Million | 821 Thousand |
| Gross Profit | 16.53 Million | 12.99 Million | 6.6 Million | 7.12 Million | -1.06 Million | -821 Thousand |
| Operating Expenses | -3.93 Billion | -3.25 Billion | 3.15 Billion | 11.51 Billion | 3.09 Billion | 2.77 Billion |
| Selling, General and Administrative Expenses | 3.93 Billion | 3.25 Billion | 892.11 Million | - | 694.82 Million | 810.67 Million |
| Research and Development Expenses | - | 1.14 Billion | 1.39 Billion | - | 1.5 Billion | 1.15 Billion |
| Other Expenses | -7.86 Billion | -6.5 Billion | 50.09 Million | 279.95 Million | 104.29 Million | 87.89 Million |
| Cost and Expenses | 12.7 Million | 13.64 Million | 3.15 Billion | 11.52 Billion | 3.09 Billion | 2.77 Billion |
| Operating Income | -3.91 Billion | -3.24 Billion | -3.14 Billion | -11.5 Billion | -3.09 Billion | -2.77 Billion |
| Interest Expense | - | 14.89 Million | 14.98 Million | 43.66 Million | 8.81 Million | 9.63 Million |
| Income Tax Expense | - | - | 563.23 Million | 1.42 Billion | 288.56 Million | 289.09 Million |
| Earnings before Tax | -2.44 Billion | -2.45 Billion | -2.72 Billion | -10.27 Billion | -2.81 Billion | -2.49 Billion |
| Net Income | -2.44 Billion | -2.45 Billion | -2.72 Billion | -10.27 Billion | -2.81 Billion | -2.49 Billion |
| Earnings Per Share Basic | -106.47 | -106.71 | -83.03 | - | -154.04 | -123.47 |
| Earnings Per Share Diluted | -106.47 | -106.71 | -83.03 | - | -154.04 | -123.47 |
| Weighted Average Shares Outstanding | 22.96 Million | 22.96 Million | 32.79 Million | 19.6 Million | 18.26 Million | 20.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.96 Million | 22.96 Million | 32.79 Million | 19.6 Million | 18.26 Million | 20.2 Million |
| Gross Margin | 0.57 | 0.49 | 0.48 | 0.52 | - | - |
| EBIT Margin | 0.57 | 0.49 | -176.85 | - | - | - |
| Profit Margin | -83.62 | -91.99 | -198.42 | -748.66 | - | - |
| EBITDA | 16.53 Million | 12.99 Million | -2.42 Billion | - | -2.72 Billion | -2.4 Billion |
| Earnings Before Tax Margin | -133.88 | -121.70 | -229.12 | -838.51 | - | - |
199800
EFGSF
1750
SWADPOL
MOHCF
ALKKO